| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |